OBESITY CLASS AND SEVERITY OF METABOLIC EMERGENCIES A SINGLE-CENTER RETROSPECTIVE FIVE-YEAR STUDY

Descargar Publicación
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment